Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wlodarczyk

Showing results (51-60 of 102) with videos related to

Pageof 11
Sort By:
Australian and New Zealand Journal of Public Health|April 1, 1997
Opportunistic blood lead testing in a paediatric inpatient populationR Aldrich, R Toneguzzi, J Wlodarczyk, et al.
Birth Defects Research|October 17, 2018
Teratogenicity of valproic acid and its constitutional isomer, amide derivative valnoctamide in miceYing Linda Lin, Meir Bialer, Robert M Cabrera, et al.
Australian and New Zealand Journal of Medicine|August 1, 1994
Accuracy of reported family history of heart disease: the impact of 'don't know' responsesJ Silberberg, J Wlodarczyk, M Hensley, et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|April 1, 2005
Role of Folbp1 in the regional regulation of apoptosis and cell proliferation in the developing neural tube and craniofaciesLouisa S Tang, Daniel R Santillano, Bogdan J Wlodarczyk, et al.
Birth Defects Research. Part A, Clinical and Molecular Teratology|July 20, 2004
Developmental consequences of abnormal folate transport during murine heart morphogenesisLouisa S Tang, Bogdan J Wlodarczyk, Daniel R Santillano, et al.
Neurotoxicology|April 20, 2006
Arsenic-induced gene expression changes in the neural tube of folate transport defective mouse embryosBogdan J Wlodarczyk, Robert M Cabrera, Denise S Hill, et al.
Journal of Medical Economics|May 20, 2009
A new model to evaluate the long-term cost effectiveness of orphan and highly specialised drugs following listing on the Australian Pharmaceutical Benefits Scheme: the Bosentan Patient RegistryAj Owen, J Spinks, A Meehan, et al.
Annals of Internal Medicine|October 1, 1995
Using quality-control analysis of peak expiratory flow recordings to guide therapy for asthmaP G Gibson, J Wlodarczyk, M J Hensley, et al.
Pediatric Pulmonology|January 1, 1991
Asthma in the vicinity of power stations: II. Outdoor air quality and symptomsR L Henry, H A Bridgman, J Wlodarczyk, et al.
Australian and New Zealand Journal of Medicine|March 4, 1998
Reproducibility of brachial ultrasonography and flow-mediated dilatation (FMD) for assessing endothelial functionK L Hardie, S Kinlay, D B Hardy, et al.
Pageof 11

Showing results (51-60 of 102) with videos related to

Sort By:
Pageof 11
Australian and New Zealand Journal of Public Health|April 1, 1997
Opportunistic blood lead testing in a paediatric inpatient populationR Aldrich, R Toneguzzi, J Wlodarczyk, et al.
Birth Defects Research|October 17, 2018
Teratogenicity of valproic acid and its constitutional isomer, amide derivative valnoctamide in miceYing Linda Lin, Meir Bialer, Robert M Cabrera, et al.
Australian and New Zealand Journal of Medicine|August 1, 1994
Accuracy of reported family history of heart disease: the impact of 'don't know' responsesJ Silberberg, J Wlodarczyk, M Hensley, et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|April 1, 2005
Role of Folbp1 in the regional regulation of apoptosis and cell proliferation in the developing neural tube and craniofaciesLouisa S Tang, Daniel R Santillano, Bogdan J Wlodarczyk, et al.
Birth Defects Research. Part A, Clinical and Molecular Teratology|July 20, 2004
Developmental consequences of abnormal folate transport during murine heart morphogenesisLouisa S Tang, Bogdan J Wlodarczyk, Daniel R Santillano, et al.
Neurotoxicology|April 20, 2006
Arsenic-induced gene expression changes in the neural tube of folate transport defective mouse embryosBogdan J Wlodarczyk, Robert M Cabrera, Denise S Hill, et al.
Journal of Medical Economics|May 20, 2009
A new model to evaluate the long-term cost effectiveness of orphan and highly specialised drugs following listing on the Australian Pharmaceutical Benefits Scheme: the Bosentan Patient RegistryAj Owen, J Spinks, A Meehan, et al.
Annals of Internal Medicine|October 1, 1995
Using quality-control analysis of peak expiratory flow recordings to guide therapy for asthmaP G Gibson, J Wlodarczyk, M J Hensley, et al.
Pediatric Pulmonology|January 1, 1991
Asthma in the vicinity of power stations: II. Outdoor air quality and symptomsR L Henry, H A Bridgman, J Wlodarczyk, et al.
Australian and New Zealand Journal of Medicine|March 4, 1998
Reproducibility of brachial ultrasonography and flow-mediated dilatation (FMD) for assessing endothelial functionK L Hardie, S Kinlay, D B Hardy, et al.
Pageof 11